5
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Levofloxacin: a Suitable Option for the Infectious Disease Consultant

, &
Pages 22-24 | Published online: 27 Oct 2016

References

  • Hurst M, Lamb HM, Scott LJ, Figgitt DP. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs. 2002; 62: 2127–67.
  • Viale P, Scudeller L, Petrosillo N, et al. Clinical stability in human immunodeficiency virus-infected patients with community- acquired pneumonia. Clin Infect Dis 2004; 38: 271–9
  • Pea F, Di Qual E, Cusenza A, et al. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clin Pharmacokinet 2003; 42: 589–98.
  • Greenberg RN, Newman MT, Shariaty S, Pectol RW. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000; 44(1): 164–6.
  • Geddes A, Thaler M, Schonwald S et al. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/ sepsis: comparison with imipenem/cilastatin in an open, randomized trial. J Antimicrob Chemother 1999; 44: 799–810.
  • Marchetti F, Viale P. Current and future perspectives for levofloxacin in severe Pseudomonas aeruginosa infections. J Chemother 2003; 15: 315–22.
  • Peacock JE, Herrington DA, Wade JC et al. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. Ann Intern Med 2002; 137(2): 77–87.
  • Chambers H F, Liu Q X, Chow Ll Hackbarth C. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 2742–6.
  • Pea F Pavan P, Nascimben E et al. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob Agents Chemother 2003; 47: 3104–8.
  • Flatz L, Cottagnoud M, Kühn F et al. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. J Antimicrob Chemother 2004; 53: 305–10.
  • Kuhn F, Cottagnoud M, Acosta F, et al. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin- resistant mutants in vitro. Antimicrob Agents Chemother 2003; 47(8): 2487–91.
  • Garcia Escudero A, Martin Gonzalez M, Gimenez Garrido F et al. A prospective, controlled, non-randomized study of three cohorts to test the effectiveness of two antibiotics levofloxacin and cotrimoxazole on antibacterial prophylaxis in neutropenic patients. Med Clin (Barc). 2003; 120: 321–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.